Trump Officials Move to Lower Drug Prices by Passing On Rebates to Patients
By ROBERT PEAR from NYT U.S.
https://nyti.ms/2Bg8dJM
The change would disrupt longstanding payment arrangements in the pharmaceutical industry, which could lower patients’ costs but could also have unintended consequences.
No comments:
Post a Comment